Ledger.Open graph →
SEC Form D · filed August 11, 2020

Orbus Therapeutics, Inc

Offering
$27.0M
Sold
$10.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
PALO ALTO, CA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (20)

Michael D. Wasserman · Palo Alto, CADirectorJason D. Levin · Palo Alto, CAExec · DirectorRobert M. Myers · Palo Alto, CAExec · DirectorErnest D. Mario · Palo Alto, CADirectorElisha (Terry) D. Gould · Palo Alto, CADirectorPatrick D. Enright · Palo Alto, CADirectorKurt D. Von Emster · Palo Alto, CADirectorRichard Silas · VANCOUVER, British Columbia, CanadaExec · DirectorSusan E. Fasig · Cincinnati, OHExec · DirectorJoseph Gabor · Thornton, PADirectorGary R. Price · Cincinnati, OHDirectorRick Trotman · VANCOUVER, British Columbia, CanadaDirectorJulie T. Thomas · Cincinnati, OHDirectorKurt D. Von Emster · Palo Alto, CADirectorSharding Management Management LLC · Dover, DEDirectorKingsley Advani · Dover, DEDirectorVilleneuve Robin · Quebec, Quebec, CanadaExec · DirectorJeffrey A. Coopersmith · Columbus, OHDirectorJames L. Hall · Salt Lake City, UTDirectorFrancois Goulet · Montreal, Quebec, CanadaExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗